[CITATION][C] Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent, Front. Pharmacol.. 11 (2020) 1817

NNM Anuar, NSN Hisam, SL Liew, A Ugusman - 2020
Save Cite Cited by 2 Related articles